Attached files

file filename
8-K - FORM 8-K - AXON ENTERPRISE, INC.d385396d8k.htm

Exhibit 99.1

FOR RELEASE ON: July 26, 2012 at 7:30 a.m. ET

 

      CONTACT:    Dan Behrendt
         Chief Financial Officer
         TASER International, Inc.
         (480) 905-2000

TASER International Reports Second Quarter Results

Q2 Sales of $28.2 million increases 33% year-over-year with Operating Income of $6.1 million

SCOTTSDALE, Ariz., July 26, 2012 — TASER International, Inc. (NASDAQ: TASR), today announced financial results for the second quarter of 2012 ended June 30, 2012.

Financial Summary:

 

  -

Net sales were $28.2 million in the quarter, an increase of $7.0 million or 33.1% compared to second quarter 2011 sales of $21.2 million. The increase in sales versus the prior year was primarily driven by the extended upgrade program for the TASER® X2™ Electronic Control Device (ECD), as well as a significant order from an international customer in Brazil.

 

  - Gross margin in the second quarter of 2012 was 58.5%, compared to 57.8% in the same period last year. The improvement in gross margin was driven by the increase in sales as well as an absence of expenses relating to a discontinued product line which was impaired in the second quarter of 2011.

 

  - Revenues in the ECD business segment increased 8% sequentially, from $24.8 million in the first quarter of 2012 to $26.9 million in the second quarter of 2012.

 

  - Revenues in the video business segment increased 47% sequentially, from $884K in the first quarter of 2012 to $1.3 million in the second quarter of 2012.

 

  - Operating income of $6.1 million benefited from the continued decrease in consulting and lobbying expenses and reduction in depreciation expense as a result of writing down the X3 and AXON product lines in Q4 2011.

 

  - Sales, general and administrative (SG&A) expenses of $8.4 million in the second quarter of 2012 decreased approximately $0.7 million compared to the second quarter of 2011 due to ongoing cost reduction efforts.

 

  - Research and development (R&D) expenses decreased $0.8 million to $2.0 million in the second quarter of 2012 when compared to the second quarter of 2011. The decrease was primarily attributable to the continued reduction in professional and consulting fees.


  - Adjusted operating income, which excludes the impact of stock-based compensation charges, depreciation and amortization and one-time litigation judgment expenses, was $8.4 million for the second quarter of 2012, a significant increase from an adjusted operating income of $1.2 million in the second quarter of 2011. GAAP income from operations was $6.1 million for the quarter, compared to a loss from operations of approximately $5.0 million for the second quarter of 2011.

 

  - Net income for the second quarter of 2012 was $3.4 million, or $0.06 per share on a basic and diluted basis.

 

  - In the second quarter of 2012, the Company generated $9.7 million in cash from operating activities. The Company generated $13.4 million in cash from operating activities in the first half of 2012.

 

  - Cash, cash equivalents and investments were $23.2 million at the end of the second quarter of 2012, after executing $16.1 million of stock repurchases during the quarter. The Company has no debt recorded on its balance sheet.

“Our momentum remained strong this quarter as the extended upgrade program of the X2 ECD encouraged further deployment across various law enforcement agencies and drove greater than thirty percent year-over-year top-line growth in our business,” commented Rick Smith, CEO of TASER International, Inc. “Further, tighter cost controls, improving expense discipline and higher sales all helped the Company deliver a second consecutive quarter of strong operating results and resulted in significant cash generation of more than $9.7 million from operations. We continue to believe that we are well positioned to deliver on the execution of our strategy, while driving profitable growth and value for all of our stakeholders.”

Other Significant Events:

 

- The Company continued to see adoption of the new X2 ECD platform by agencies through its extended upgrade program. The Company announced a number of significant orders that occurred during the second quarter, which included:

 

   

Breon Enterprises of Australia (AUS) purchased 775 X2 ECDs with 475 TASER CAM™ HD cameras in addition to X26 ECDs, TASER CAM audio recorders, TASER Cartridges and related accessories.

 

   

The Oregon State Police (OR) purchased 454 X2 ECDs as a full deployment to their patrol, fish and wildlife troopers.

 

   

The North Carolina State Highway Patrol (NC) purchased 422 X2 ECDs.

 

   

The Manchester Police Department (NH) purchased 250 X2 ECDs.

 

   

The Las Vegas Metropolitan Police Department (NV) purchased 162 X2 ECDs and various related accessories.

 

- The Company also announced the following significant orders relating to the X26 ECD:

 

   

A Brazilian law enforcement agency purchased 800 X26 ECDs and related accessories.


   

The Ohio State Highway Patrol (OH) purchased 485 X26 ECDs.

 

   

The Austin Police Department (TX) purchased 100 X26 ECDs with extended warranties and related accessories.

 

-

The Company began shipping the new TASER AXON™ Flex™ on-officer camera and EVIDENCE.com management service in May. A number of new agencies adopted the platform during the second quarter including:

 

   

The Mesa Police Department (AZ) ordered 50 AXON Flex cameras with one year of EVIDENCE.com.

 

   

The Terrebonne Parish Sheriff’s Office (LA) ordered 20 AXON Flex cameras with three years of EVIDENCE.com.

 

   

The Modesto Police Department (CA) ordered 131 AXON Flex cameras with one year of EVIDENCE.com.

 

   

The Bay Area Rapid Transit (BART) Police (CA) expanded their initial order from the first quarter to a full deployment with a total of 220 AXON Flex units with three years of EVIDENCE.com.

 

- On April 25, 2012 the Board of Directors of TASER authorized a new share repurchase program for up to $20 million of its common stock, reflecting the company’s strong balance sheet and free-cash-flow generation. Repurchases may take place from time to time on the open market and are subject to market and business conditions. As of June 30, 2012 the Company has repurchased 5.6% of shares outstanding totaling 3,113,806 shares of stock costing approximately $16.1 million. In the past eighteen months, the Company has repurchased a total of 10,578,389 shares or 16.9% of the total shares outstanding at the start of the buyback programs. At June 30, 2012 the Company had 52,830,153 shares outstanding.

Outlook:

“As we move forward into the second half of the year, we remain encouraged by the continued traction we are seeing with the adoption of the X2, both in the domestic and international markets,” commented Rick Smith, CEO of TASER International, Inc. “The X2 product line witnessed more than 120% revenue growth sequentially in the second quarter and our pipeline and sales conversations remain robust. Law enforcement agencies remain eager to harness the new technology of the X2 and want to take advantage of our generous trade-in program to upgrade their existing X26 devices. Further, we are also seeing highly encouraging market reaction to the new AXON Flex video system which anchored a 46% sequential increase in revenue for our video business. Mid-size agencies like BART and Modesto Police Departments moved to full deployment of the devices to every officer within weeks of the product shipping. We are also seeing significant interest in the major cities, with the Mesa Police Department and the Fort Worth Police Department making initial deployments of fifty units each. We look forward to the accelerating traction of AXON Flex, as well as the EVIDENCE.COM service over the coming quarters.”

The Company will host its second quarter 2012 earnings conference call on Thursday, July 26, 2012 at 11:00 a.m. ET. To join the live audio presentation, please dial toll free at 888-771-4371 or 847-585-4405 for international callers. The pass code is 32944812.


Non-GAAP Measures

To supplement the Company’s Statements of Operations presented in accordance with GAAP, we are presenting non-GAAP measures of certain components of financial performance. We have presented these measures for our investors to be better able to compare our current results with those of previous periods and have shown a reconciliation of GAAP to the non-GAAP financial measures in the tables at the end of this release. These non-GAAP measures include the impact of non-cash stock-based compensation expense, depreciation and amortization, litigation judgment expense, asset impairment charges and loss on write down of Property and Equipment. We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenses and expenditures that may not be indicative of our “recurring core business operating results,” meaning our operating performance excluding non-cash charges, such as stock-based compensation, depreciation and amortization and other discrete non-cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance and liquidity.

Caution on Use of Non-GAAP Measures

As noted previously, these non-GAAP financial measures are not consistent with GAAP because they do not reflect the impact of other non-cash charges. Management believes investors will benefit from greater transparency in referring to these non-GAAP financial measures when assessing the Company’s operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:

 

these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company’s GAAP financial measures;

 

these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company’s GAAP financial measures;

 

these non-GAAP financial measures should not be considered to be superior to the Company’s GAAP financial measures; and

 

these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principles.


Further, these non-GAAP financial measures may be unique to the Company, as they may be different from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company’s results to the results of other companies.

A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure or measures appears at the end of this press release.

About TASER International, Inc.

TASER International, Inc. (NASDAQ:TASR) is a global provider of safety technologies that protect life and prevent conflict. More than 16,575 public safety agencies in 107 countries rely on TASER® electronic control devices and AXON on-officer camera systems to help protect and serve. Today, the use of TASER ECDs has saved more than 93,000 lives from potential death or serious injury while TASER innovations benefit individuals and families too, providing personal protection and accountability while maintaining regard for life. Since 1994, more than 241,000 individuals have relied on TASER technology as a means for effective personal safety. Learn more about TASER International and its solutions at www.TASER.com and www.EVIDENCE.com or by calling (800) 978-2737. Be a part of the TASER community by joining us on Facebook, LinkedIn, Twitter, and YouTube.

TASER® is a registered trademark of TASER International, Inc., registered in the U.S. All rights reserved. TASER logo, AXON, AXON Flex, TASER CAM, TASER CAM HD, X26, X2, and X3 are trademarks of TASER International, Inc.

Note to Investors

To review the TASER International Safe Harbor Statement, please visit:

http://investor.taser.com/phoenix.zhtml?c=129937&p=irol-safeharbor.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Such forward-looking statements relate to: expected revenue and earnings growth; estimations regarding the size of our target markets; successful penetration of the law enforcement market; expansion of product sales to the private security, military and consumer self-defense markets; growth expectations for new and existing accounts; expansion of production capability; new product introductions; product safety and our business model. We caution that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements herein.


TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) potential delays in international and domestics orders; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.

For investor relations information please contact Erin Curtis by phone at 480-515-6330 or via email at IR@TASER.com, or Dan Behrendt, Chief Financial Officer of TASER International, Inc., 480-905-2002.

- more -


TASER International, Inc.

Consolidated Statements of Operations

(Unaudited)

 

     For the Three Months Ended  
     June 30, 2012      June 30, 2011  

Net sales

   $ 28,222,443       $ 21,198,055   

Cost of products sold

     11,720,070         8,956,362   
  

 

 

    

 

 

 

Gross margin

     16,502,373         12,241,693   

Sales, general and administrative expenses

     8,404,611         9,065,847   

Research and development expenses

     2,038,830         2,793,235   

Litigation judgment expense

     —           3,301,243   

Asset impairment

     —           1,350,504   

Loss on write down / disposal of property and equipment, net

     —           747,409   
  

 

 

    

 

 

 

Income (loss) from operations

     6,058,932         (5,016,545

Interest and other (expense) income, net

     7,133         1,261,885   
  

 

 

    

 

 

 

Income before provision for income taxes

     6,066,064         (3,754,660

Provision (benefit) for income taxes

     2,623,818         (1,459,828
  

 

 

    

 

 

 

Net income (loss)

   $ 3,442,246       $ (2,294,832
  

 

 

    

 

 

 

Income (loss) per common and common equivalent shares

     

Basic

   $ 0.06       $ (0.04

Diluted

   $ 0.06       $ (0.04

Weighted average number of common and common equivalent shares outstanding

     

Basic

     54,520,889         60,605,140   

Diluted

     55,166,644         60,605,140   


TASER International, Inc.

Consolidated Statements of Operations

(Unaudited)

 

     For the Six Months Ended  
     June 30, 2012     June 30, 2011  

Net sales

   $ 53,863,835      $ 44,315,004   

Cost of products sold

     22,120,203        19,865,649   
  

 

 

   

 

 

 

Gross margin

     31,743,631        24,449,355   

Sales, general and administrative expenses

     17,258,633        18,401,230   

Research and development expenses

     4,171,050        5,545,699   

Litigation judgment expense

     (2,200,000     3,301,243   

Asset impairment

     —          1,350,504   

Loss on write down / disposal of property and equipment, net

     —          757,038   
  

 

 

   

 

 

 

Income (loss) from operations

     12,513,948        (4,906,359

Interest and other income (expense), net

     14,127        1,288,206   
  

 

 

   

 

 

 

Income (loss) before provision for income taxes

     12,528,075        (3,618,153

Provision (benefit) for income taxes

     5,282,011        (1,343,053
  

 

 

   

 

 

 

Net income

   $ 7,246,064      $ (2,275,100
  

 

 

   

 

 

 

Income (loss) per common and common equivalent shares

    

Basic

   $ 0.12      $ (0.04

Diluted

   $ 0.12      $ (0.04

Weighted average number of common and common equivalent shares outstanding

    

Basic

     58,849,010        61,515,979   

Diluted

     59,482,674        61,515,979   


TASER International, Inc.

Segment Reporting

(Unaudited)

 

    For the Three Months Ended  
    June 30, 2012     June 30, 2011  
    Video     ECD     Total     Video     ECD     Total  

Product sales

    1,164,128        26,931,727        28,095,855        664,868        20,450,150        21,115,018   

Service revenue

    126,588        —          126,588        83,037        —          83,037   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

  $ 1,290,716      $ 26,931,727      $ 28,222,443      $ 747,905      $ 20,450,150      $ 21,198,055   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of products sold

    736,924        9,783,886        10,520,810        550,501        7,203,441        7,753,942   

Cost of service delivered

    1,199,260        —          1,199,260        1,202,420        —          1,202,420   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of sales

    1,936,184        9,783,886        11,720,070        1,752,921        7,203,441        8,956,362   

Gross margin

    (645,468     17,147,841        16,502,373        (1,005,016     13,246,709        12,241,693   

Sales, general and administrative expenses

    735,957        7,668,654        8,404,611        765,921        8,299,926        9,065,847   

Research and development expenses

    1,116,746        922,084        2,038,830        1,144,300        1,648,935        2,793,235   

Litigation judgment expense

    —          —          —          —          3,301,243        3,301,243   

Asset impairment

    —          —          —          —          1,350,504        1,350,504   

Loss on write down / disposal of property and equipment, net

    —          —          —          711,243        36,166        747,409   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations

  $ (2,498,171   $ 8,557,103      $ 6,058,932      $ (3,626,480   $ (1,390,065   $ (5,016,545
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations, normalized

  $ (2,498,171   $ 8,557,103      $ 6,058,932      $ (2,915,237   $ 3,297,848      $ 382,611   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating margin %

    -194     32     21     -485     -7     -24

Operating margin %,normalized

    -194     32     21     -390     16     2
    For the Six Months Ended  
    June 30, 2012     June 30, 2011  
    Video     ECD     Total     Video     ECD     Total  

Product sales

    1,936,259        51,689,401        53,625,660        1,495,124        42,663,989        44,159,113   

Service revenue

    238,175        —          238,175        155,891        —          155,891   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

  $ 2,174,434      $ 51,689,401      $ 53,863,835      $ 1,651,015      $ 42,663,989      $ 44,315,004   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of products sold

    1,530,772        18,395,305        19,926,077        1,262,444        16,249,223        17,511,667   

Cost of service delivered

    2,194,126        —          2,194,126        2,353,982        —          2,353,982   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of sales

    3,724,898        18,395,305        22,120,203        3,616,426        16,249,223        19,865,649   

Gross margin

    (1,550,464     33,294,096        31,743,632        (1,965,411     26,414,766        24,449,355   

Sales, general and administrative expenses

    1,503,482        15,755,151        17,258,633        1,539,731        16,861,499        18,401,230   

Research and development expenses

    2,408,614        1,762,436        4,171,050        2,227,202        3,318,497        5,545,699   

Litigation judgment (benefit) expense

    —          (2,200,000     (2,200,000     —          3,301,243        3,301,243   

Asset impairment

    —          —          —          —          1,350,504        1,350,504   

Loss on write down / disposal of property and equipment, net

    —          —          —          711,243        45,795        757,038   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations

  $ (5,462,560   $ 17,976,509      $ 12,513,949      $ (6,443,587   $ 1,537,228      $ (4,906,359
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations, normalized

  $ (5,462,560   $ 15,776,509      $ 10,313,949      $ (5,732,344   $ 6,234,770      $ 502,426   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating margin %

    -251     35     23     -390     4     -11

Operating margin %,normalized

    -251     31     19     -347     15     1


TASER International, Inc.

Reconciliation of GAAP to Non-GAAP Financial Measures

(Unaudited)

 

     For the Three Months Ended  
     June 30, 2012      June 30, 2011  
     Video     ECD      Total      Video     ECD     Total  

GAAP (loss) income from operations

   $ (2,498,169   $ 8,557,101       $ 6,058,932       $ (3,626,479   $ (1,390,066   $ (5,016,545

Stock-based compensation expense (a)

     87,719        501,972         589,691         106,637        770,371        877,007   

Depreciation and amortization

     640,095        1,067,237         1,707,332         472,521        1,548,451        2,020,972   

Litigation judgment expense

     —          —           —           —          3,301,243        3,301,243   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted operating (loss) income

   $ (1,770,355   $ 10,126,309       $ 8,355,954       $ (3,047,321   $ 4,229,998      $ 1,182,677   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

 

a) Results include stock-based compensation as follows:

 

     For the Three Months Ended  
     June 30, 2012      June 30, 2011  

Cost of products sold

   $ 28,748       $ 51,976   

Sales, general and administrative expenses

     426,314         649,566   

Research and development expenses

     134,629         175,465   
  

 

 

    

 

 

 
   $ 589,691       $ 877,007   
  

 

 

    

 

 

 

 

     For the Six Months Ended  
     June 30, 2012     June 30, 2011  
     Video     ECD     Total     Video     ECD      Total  

GAAP (loss) income from operations

   $ (5,462,558   $ 17,976,506      $ 12,513,948      $ (6,443,587   $ 1,537,228       $ (4,906,359

Stock-based compensation expense (a)

     186,114        1,100,998        1,287,112        227,368        1,612,556         1,839,924   

Depreciation and amortization

     1,112,989        2,226,220        3,339,209        1,135,948        2,923,803         4,059,751   

Litigation judgment (benefit) expense

     —          (2,200,000     (2,200,000     —          3,301,243         3,301,243   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Adjusted operating (loss) income

   $ (4,163,455   $ 19,103,725      $ 14,940,269      $ (5,080,271   $ 9,374,830       $ 4,294,559   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

a) Results include stock-based compensation as follows:

 

     For the Six Months Ended  
     June 30, 2012      June 30, 2011  

Cost of products sold

   $ 62,163       $ 104,980   

Sales, general and administrative expenses

     956,291         1,372,745   

Research and development expenses

     268,658         362,199   
  

 

 

    

 

 

 
   $ 1,287,112       $ 1,839,924   
  

 

 

    

 

 

 


TASER International, Inc.

Consolidated Balance Sheets

(Unaudited)

 

     June 30, 2012     December 31, 2011  
ASSETS     

Current Assets:

    

Cash and cash equivalents

   $ 17,970,019      $ 21,300,733   

Short-term investments

     5,186,263        5,108,189   

Accounts receivable, net of allowance of $450,000 at June 30, 2012 and December 31, 2011, respectively

     14,696,073        11,780,135   

Inventory

     10,466,858        11,484,761   

Prepaid expenses and other current assets

     2,192,802        2,089,676   

Deferred income tax assets, net

     6,783,830        9,968,929   
  

 

 

   

 

 

 

Total current assets

     57,295,845        61,732,423   

Property and equipment, net

     24,117,667        26,845,220   

Deferred income tax assets, net

     12,716,169        12,716,169   

Intangible assets, net

     3,336,419        3,224,006   

Other long-term assets

     294,219        444,933   
  

 

 

   

 

 

 

Total assets

   $ 97,760,319      $ 104,962,751   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current Liabilities:

    

Accounts payable

   $ 3,932,328      $ 4,513,938   

Accrued liabilities

     6,582,285        7,643,004   

Current portion of deferred revenue

     3,573,020        3,317,641   

Customer deposits

     731,196        413,314   
  

 

 

   

 

 

 

Total current liabilities

     14,818,829        15,887,897   

Deferred revenue, net of current portion

     5,642,056        4,636,901   

Liability for unrecorded tax benefits

     2,012,366        1,982,399   
  

 

 

   

 

 

 

Total liabilities

     22,473,251        22,507,197   
  

 

 

   

 

 

 

Commitments and Contingencies

    

Stockholders’ Equity

    

Preferred stock, $0.00001 par value per share; 25 million shares authorized; no shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively

     —          —     

Common stock, $0.00001 par value per share; 200 million shares authorized; 52,830,153 and 55,696,608 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively

     655        652   

Additional paid-in capital

     103,342,170        101,597,626   

Treasury stock, 12,669,989 and 2,091,600 shares at June 30, 2012 and December 31, 2011, respectively

     (63,345,644     (47,207,093

Retained earnings

     35,391,390        28,145,325   

Accumulated other comprehensive loss

     (101,503     (80,956
  

 

 

   

 

 

 

Total stockholders’ equity

     75,287,068        82,455,554   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 97,760,319      $ 104,962,751   
  

 

 

   

 

 

 


TASER International, Inc.

Selected Consolidated Statement of Cash Flows Information

(Unaudited)

 

     For the Six Months Ended  
     June 30, 2012     June 30, 2011  

Net income (loss)

   $ 7,246,064      $ (2,275,100

Depreciation and amortization

     3,339,209        4,117,580   

Stock-based compensation expense

     1,287,112        1,839,924   

Net cash provided by operating activities

     13,384,506        9,155,093   

Net cash used by investing activities

     (968,175     (11,648,260

Net cash used by financing activities

     (15,741,666     (12,495,893

Cash and cash equivalents, end of period

   $ 17,970,019      $ 27,719,405